Late diagnosis and an inability to personalize treatment are major problems preventing reductions in pancreatic cancer mortality. In 2015, the identification of a highly discriminatory exosomal biomarker, culture systems that recapitulate human disease and new methods of analysing large data sets to identify prognostic markers have improved the future outlook for patients with this cancer.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Extracellular vesicle biomarkers for pancreatic cancer diagnosis: a systematic review and meta-analysis
BMC Cancer Open Access 23 May 2022
-
Gene coexpression network approach to develop an immune prognostic model for pancreatic adenocarcinoma
World Journal of Surgical Oncology Open Access 12 April 2021
-
Functional polymorphisms in LncRNA HOTAIR contribute to susceptibility of pancreatic cancer
Cancer Cell International Open Access 28 February 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74, 2913–2921 (2014).
Gui, J. C. et al. CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis. Clin. Exp. Med. 14, 225–233 (2014).
Poruk, K. E. et al. The clinical utility of CA 19–9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr. Mol. Med. 13, 340–351 (2013).
Ghatnekar, O. et al. Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature. Int. J. Cancer 133, 2392–2397 (2013).
Melo, S. A. et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523, 177–182 (2015).
Zill, O. A. et al. Cell-free DNA next-generation sequencing in pancreatobiliary carcinomas. Cancer Discov. 5, 1040–1048 (2015).
Gentles, A. J. et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat. Med. 21, 938–945 (2015).
Moffitt, R. A. et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet. 47, 1168–1178 (2015).
Boj, S. F. et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160, 324–338 (2015).
Huang, L. et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nat. Med. 21, 1364–1371 (2015).
Acknowledgements
The authors are supported by funding from the Deutsche Krebshilfe / Dr. Mildred-Scheel-Stiftung (109102), the Deutsche Forschungsgemeinschaft (DFG GRK1947-A3, MA 4115/1-2/3) and the European Union (EU-FP-7: EPC-TM and EU-FP7-REGPOT-2010-1).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Seufferlein, T., Mayerle, J. Precision medicine in pancreatic cancer — fact or fiction?. Nat Rev Gastroenterol Hepatol 13, 74–75 (2016). https://doi.org/10.1038/nrgastro.2015.215
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2015.215
This article is cited by
-
Extracellular vesicle biomarkers for pancreatic cancer diagnosis: a systematic review and meta-analysis
BMC Cancer (2022)
-
Gene coexpression network approach to develop an immune prognostic model for pancreatic adenocarcinoma
World Journal of Surgical Oncology (2021)
-
MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer
Cellular Oncology (2021)
-
Functional polymorphisms in LncRNA HOTAIR contribute to susceptibility of pancreatic cancer
Cancer Cell International (2019)
-
Organoidomics — falling star or new galaxy in pancreatic cancer?
Nature Reviews Gastroenterology & Hepatology (2018)